Mihir Shah - 23 May 2023 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Financial Officer
Signature
By: Mark Hueppelsheuser For: Mihir Shah
Issuer symbol
TOI
Transactions as of
23 May 2023
Transactions value $
-$1,473
Form type
4
Filing time
24 May 2023, 20:43:26 UTC
Previous filing
21 Mar 2023
Next filing
18 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Disposed to Issuer -$1.1K -2.57K -1.13% $0.43 224K 23 May 2023 Direct F1, F2
transaction TOI Common Stock Disposed to Issuer -$372 -869 -0.39% $0.43 223K 23 May 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
F2 Price is the volume weighted average selling price of all sales by the Reporting Person on May 23, 2023 within a one-dollar range. Actual prices ranged from $0.4201 to $0.4600. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.